<?xml version="1.0" ?>
<!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd">
<pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article">
  <?properties open_access?>
  <front>
    <journal-meta>
      <journal-id journal-id-type="nlm-ta">BMC Res Notes</journal-id>
      <journal-id journal-id-type="iso-abbrev">BMC Res Notes</journal-id>
      <journal-title-group>
        <journal-title>BMC Research Notes</journal-title>
      </journal-title-group>
      <issn pub-type="epub">1756-0500</issn>
      <publisher>
        <publisher-name>BioMed Central</publisher-name>
        <publisher-loc>London</publisher-loc>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="pmid">25113505</article-id>
      <article-id pub-id-type="pmc">4267432</article-id>
      <article-id pub-id-type="publisher-id">3050</article-id>
      <article-id pub-id-type="doi">10.1186/1756-0500-7-515</article-id>
      <article-categories>
        <subj-group subj-group-type="heading">
          <subject>Case Report</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Solitary fibrous tumors of the pleura
with Doege-Potter syndrome: a case report and three-decade review of the
literature</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author" equal-contrib="yes">
          <name>
            <surname>Meng</surname>
            <given-names>Wen</given-names>
          </name>
          <address>
            <email>mengwentaian@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author" corresp="yes" equal-contrib="yes">
          <name>
            <surname>Zhu</surname>
            <given-names>Hong-Hong</given-names>
          </name>
          <address>
            <email>hozhu@jhsph.edu</email>
          </address>
          <xref ref-type="aff" rid="Aff6"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Li</surname>
            <given-names>Hu</given-names>
          </name>
          <address>
            <email>li_huhospital@sina.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wang</surname>
            <given-names>Guoqing</given-names>
          </name>
          <address>
            <email>wangguoqing1956@sina.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Wei</surname>
            <given-names>Dongshan</given-names>
          </name>
          <address>
            <email>wds19770108@163.com</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <contrib contrib-type="author">
          <name>
            <surname>Feng</surname>
            <given-names>Xing</given-names>
          </name>
          <address>
            <email>fengxing1979@yeah.net</email>
          </address>
          <xref ref-type="aff" rid="Aff5"/>
        </contrib>
        <aff id="Aff5"><label/>Department of Cardiothoracic Surgery, Hangzhou First People&#x2019;s Hospital, Hangzhou, 310006 Zhejiang Province P R China </aff>
        <aff id="Aff6"><label/>Department of Public Health, College of Health and Human
Service, Western Kentucky University, Bowling Green, KY 42101 USA </aff>
      </contrib-group>
      <pub-date pub-type="epub">
        <day>11</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="pmc-release">
        <day>11</day>
        <month>8</month>
        <year>2014</year>
      </pub-date>
      <pub-date pub-type="collection">
        <year>2014</year>
      </pub-date>
      <volume>7</volume>
      <elocation-id>515</elocation-id>
      <history>
        <date date-type="received">
          <day>16</day>
          <month>9</month>
          <year>2013</year>
        </date>
        <date date-type="accepted">
          <day>18</day>
          <month>7</month>
          <year>2014</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>&#xA9; Meng et al.; licensee BioMed Central Ltd. 2014</copyright-statement>
        <license license-type="open-access">
          <license-p>This article is published under license to BioMed Central Ltd. This is
an Open Access article distributed under the terms of the Creative Commons
Attribution License (<ext-link ext-link-type="uri" xlink:href="http://creativecommons.org/licenses/by/2.0">http://creativecommons.org/licenses/by/2.0</ext-link>), which permits unrestricted use, distribution, and reproduction in
any medium, provided the original work is properly credited.</license-p>
        </license>
      </permissions>
      <abstract id="Abs1">
        <sec>
          <title>Background</title>
          <p>No case of solitary fibrous tumor of the pleura with Doege-Potter syndrome has
been reported in China. This study was to report a rare repeatedly recurrent case
of solitary fibrous tumor of the pleura with Doege-Potter syndrome diagnosed in
China and a three-decade literature review of solitary fibrous tumor of the pleura
with Doege-Potter syndrome worldwide.</p>
        </sec>
        <sec>
          <title>Case presentation</title>
          <p>A rare case of solitary fibrous tumor of the pleura with Doege-Potter syndrome
was diagnosed in 2005 with follow-up to 2011. All medical records were collected
and literature of solitary fibrous tumor of the pleura with Doege-Potter syndrome
from 1979 to 2011 was obtained through Medline. This typical case, diagnosed and
confirmed by histopathologic results, was a 72-year-old Chinese woman who had a
complaint of night sweat for a month. A localized mass 12&#xA0;cm &#xD7; 11&#xA0;cm &#xD7; 8&#xA0;cm in
size was found associated with pleural effusion in her left low chest cavity, and
blood tests showed severe hypoglycemia. Removal of the mass solved the
hypoglycemia. The case was repeatedly recurrent in April, 2010 and March, 2011 and
had no signs of recurrence up to the end of 2011 after surgery. A review of 45
cases of solitary fibrous tumor of the pleura with Doege-Potter syndrome compared
and summarized clinical characteristics, treatments, and outcomes by benign and
malignant tumor nature.</p>
        </sec>
        <sec>
          <title>Conclusions</title>
          <p>Incidence of solitary fibrous tumor of the pleura with Doege-Potter syndrome
is similar between genders. There are no significant differences in clinical
characteristics between benign and malignant cases. Surgery is the first effective
treatment for solitary fibrous tumor of the pleura with Doege-Potter syndrome and
the completeness of the initial resection is the key to preventing recurrence.
Routine follow-up examinations are recommended for early detection of
recurrence.</p>
        </sec>
      </abstract>
      <kwd-group xml:lang="en">
        <title>Keywords</title>
        <kwd>Solitary fibrous tumors of pleura</kwd>
        <kwd>Doege-Potter syndrome</kwd>
        <kwd>Surgery</kwd>
        <kwd>Case report review</kwd>
      </kwd-group>
      <custom-meta-group>
        <custom-meta>
          <meta-name>issue-copyright-statement</meta-name>
          <meta-value>&#xA9; The Author(s) 2014</meta-value>
        </custom-meta>
      </custom-meta-group>
    </article-meta>
  </front>
  <body>
    <sec id="Sec1">
      <title>Background</title>
      <p>Solitary fibrous tumor of the pleura (SFTP) is a rare primary tumor, occupying
less than 5% of all pleural tumors [<xref ref-type="bibr" rid="CR1">1</xref>].
It arises from the submesothelial mesenchymal layer. Hypoglycemia accompanying SFTP
is specifically referred to as the Doege-Potter syndrome (DPS) [<xref ref-type="bibr" rid="CR2">2</xref>]. A large form of insulin-like growth factor 2
(IGF-2), which is probably an incompletely processed molecule of IGF-2, is derived
from the tumor and considered to be a hypoglycemic mechanism [<xref ref-type="bibr" rid="CR3">3</xref>]. England reported pathologic differences between
benign and malignant SFTP among 141 benign and 82 malignant neoplasms [<xref ref-type="bibr" rid="CR4">4</xref>] but no summary of clinical characteristics of
benign and malignant SFTP with DPS due to a small number (n&#x2009;=&#x2009;12) of DPS cases. Our
report presented a typical case of repeatedly recurrent malignant SFTP with DPS in
China, followed from 2005 to 2011. We then reviewed the literature of case reports
of SFTP with DPS from 1979 to 2011 through Medline, and compared and summarized
clinical characteristics, treatments, and outcomes by benign and malignant
nature.</p>
    </sec>
    <sec id="Sec2">
      <title>Case presentation</title>
      <p>A 72-year-old Chinese woman was hospitalized with a complaint of night sweat for
one month in January, 2005. A localized mass 12&#xA0;cm x 11&#xA0;cm x 8&#xA0;cm in size was found
associated with pleural effusion in her left low chest cavity. Blood tests showed
she was severely hypoglycemic. Removal of the mass solved the hypoglycemia. No other
treatments were given. The histopathologic result showed a solitary fibrous tumor,
potentially malignant.</p>
      <p>The patient was followed up until April, 2010 when symptoms of night sweats
returned. A physical examination showed she had no breath sound in the left low
cavity, and the percussion note was dull on the left side of her thorax. Laboratory
evaluation revealed no significant abnormalities in hematological or biochemical
profile except low blood glucose. The complete resection of the mass revealed
multiple well-capsulated masses in the left low chest cavity, the largest one 9&#xA0;cm &#xD7;
5&#xA0;cm &#xD7; 4&#xA0;cm in size. Local tumor necrosis and mitosis up to 4/10 high power fields
were microscopically identified. In March, 2011, the patient again had symptoms of
night and morning sweats, and computed tomography and X-ray revealed a large
recurrent tumor mass. The extensive excision of mass plus extensive excision of the
pleura was performed revealing multiple recurrent parietal pleural masses in the
left low chest cavity, the largest measured 14&#xA0;cm &#xD7; 10&#xA0;cm &#xD7; 10&#xA0;cm. The episodes of
hypoglycemia abated postoperatively and the patient seemed in good health after the
surgery and had no signs of recurrence when we followed her up to the end of
2011.</p>
      <sec id="Sec3">
        <title>Literature review</title>
        <p>We reviewed the literature in both English and Chinese languages from 1979 to
2011 through Medline and summarized 45 cases of SFTP with DPS and classified them
into 22 benign and 23 malignant cases based on histopathologic results, referring
to the criteria by England <italic>et al.</italic> [<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      </sec>
      <sec id="Sec4">
        <title>Summary of the 45 cases of SFTP with DPS</title>
        <sec id="Sec5">
          <title>Basic characteristics</title>
          <p>The age at diagnosis among 22 benign patients ranges from 38 to 79&#xA0;years
old, with a mean age of 60.8&#x2009;&#xB1;&#x2009;10.0 (standard deviation) and 23 malignant
patients 31 to 79&#xA0;years with a mean age of 64.1&#x2009;&#xB1;&#x2009;10.8. Twenty-four cases (12
benign and 12 malignant) are females and 21 (10 benign and 11 malignant) males.
About 86.4% of benign and 87.0% of malignant SFTP patients are diagnosed at the
ages of 50&#x2013;70 years old (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).<table-wrap id="Tab1"><label>Table 1</label><caption><p>
<bold>Summary characteristics of 45 cases of solitary
fibrous tumors of the pleura with Doege-Potter syndrome,
1979-2011</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Characteristic</th><th>Benign (n&#x2009;=&#x2009;22)</th><th>Malignant (n&#x2009;=&#x2009;23)</th><th>
<bold><italic>P</italic></bold>-value*</th></tr></thead><tbody><tr><td>Age at diagnosis (years):
Mean&#x2009;&#xB1;&#x2009;SD<sup>$</sup>
</td><td>60.8&#x2009;&#xB1;&#x2009;10.0</td><td>64.1&#x2009;&#xB1;&#x2009;10.8</td><td>0.29</td></tr><tr><td>Gender</td><td/><td/><td/></tr><tr><td>Male</td><td>10</td><td>11</td><td>0.87</td></tr><tr><td>Female</td><td>12</td><td>12</td><td/></tr><tr><td>Sign</td><td/><td/><td/></tr><tr><td>Pleural effusion</td><td>5 (n&#x2009;=&#x2009;16)</td><td>4 (n&#x2009;=&#x2009;16)</td><td>0.69</td></tr><tr><td>Clubbing in fingers</td><td>5 (n&#x2009;=&#x2009;16)</td><td>4 (n&#x2009;=&#x2009;16)</td><td>0.69</td></tr><tr><td>Skin change</td><td>2 (n&#x2009;=&#x2009;16)</td><td>1 (n&#x2009;=&#x2009;16)</td><td>0.54</td></tr><tr><td>Tumor mass</td><td/><td/><td/></tr><tr><td>Clear borders</td><td>13 (n&#x2009;=&#x2009;13)</td><td>16 (n&#x2009;=&#x2009;20)</td><td>0.09</td></tr><tr><td>Location</td><td/><td/><td/></tr><tr><td>Right</td><td>13 (n&#x2009;=&#x2009;21)</td><td>14 (n&#x2009;=&#x2009;23)</td><td>0.94</td></tr><tr><td>Left</td><td>8 (n&#x2009;=&#x2009;21)</td><td>9 (n&#x2009;=&#x2009;23)</td><td>0.94</td></tr><tr><td>Up</td><td>1 (n&#x2009;=&#x2009;17)</td><td>2 (n&#x2009;=&#x2009;20)</td><td>0.65</td></tr><tr><td>Low</td><td>16 (n&#x2009;=&#x2009;17)</td><td>18 (n&#x2009;=&#x2009;20)</td><td>0.65</td></tr><tr><td>Size (cm)</td><td/><td/><td/></tr><tr><td>&#x2264; 10</td><td>0 (n&#x2009;=&#x2009;17)</td><td>1 (n&#x2009;=&#x2009;21)</td><td/></tr><tr><td>&gt;10</td><td>17 (n&#x2009;=&#x2009;17)</td><td>20 (n&#x2009;=&#x2009;21)</td><td>0.36</td></tr><tr><td>Morphologic Features</td><td/><td/><td/></tr><tr><td>Homogeneous</td><td>2 (n&#x2009;=&#x2009;5)</td><td>3 (n&#x2009;=&#x2009;17)</td><td/></tr><tr><td>Heterogeneous</td><td>3 (n&#x2009;=&#x2009;5)</td><td>14 (n&#x2009;=&#x2009;17)</td><td>0.29</td></tr></tbody></table><table-wrap-foot><p>*Pearson <italic>P</italic>-values for all
frequency variables were estimated by individual Chi-square test and for
age at diagnosis by <italic>t</italic>-test.</p><p>
<sup>$</sup>SD: Standard deviation.</p></table-wrap-foot></table-wrap></p>
        </sec>
      </sec>
      <sec id="Sec6">
        <title>Clinical characteristics</title>
        <p>All patients have hypoglycemia-related symptoms. Abnormal consciousness,
confusion, and sweating are often seen in both benign and malignant patients.
Signs (such as pleural effusion, clubbing in fingers, and skin change) are also
seen in both benign and malignant patients (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
        <p>From the 13 benign and 20 malignant reports that have a detailed description
of the tumor mass, 100.0% benign and 80.0% malignant have sharply circumscribed
borders. Most tumors are located in the right low area of chest cavity. The size
of most benign and malignant tumors is greater than 10&#xA0;cm. The average dimension
of these SFTPs with DPS is 21.7&#x2009;&#xB1;&#x2009;5.0&#xA0;cm for benign and 17.6&#x2009;&#xB1;&#x2009;4.1&#xA0;cm for
malignant tumors. There is no significant difference in morphologic features
between benign and malignant tumors (Table&#xA0;<xref rid="Tab1" ref-type="table">1</xref>).</p>
      </sec>
      <sec id="Sec7">
        <title>Treatments and outcomes</title>
        <p>Of the 18 benign cases of SFTP with DPS with detailed surgical information, 13
(72.2%) are removed by simple excision of mass, and five cases by complex excision
that included adhesion tissue. Of the 20 malignant cases with detailed surgical
information, 11 (55.0%) are removed by simple excision, and 9 (45.0%) cases by
complex excision. No distant and lymph node metastasis are found in all cases. The
follow-up time in 29 (64.4%) of 45 cases ranges from 1 to 288&#xA0;months (average
time, 35.3&#x2009;&#xB1;&#x2009;57.2&#xA0;months). All but four (two in benign and two in malignant) of
the patients are free of recurrent SFTP with DPS. One recurrent tumor is performed
by complex excision (recurrent tumor and adherent tissue). One recurrent tumor is
performed by recurrent tumor excision. But they all are experienced repeated
relapses. The other two patients refuse medical advice based on poor lung function
and other reasons. Radiotherapy and chemotherapy are used in four malignant cases
- two with single radiotherapy and chemotherapy but none of them show any effect
or benefit. Two of three cases having detailed information of positron emission
tomography-computed tomography examination show little to moderate uptake of
[<sup>14</sup>C] fluorodeoxyglucose. Five of 20 cases given
transthoracic needle biopsy could not get diagnosed, and seven of 20 cases could
not be differentiated between benign and malignant SFTP due to limitation of
tissue (Table&#xA0;<xref rid="Tab2" ref-type="table">2</xref>).<table-wrap id="Tab2"><label>Table 2</label><caption><p>
<bold>Treatment and outcome of 45 cases of solitary
fibrous tumors of pleura with Doege-Potter syndrome,
1979-2011</bold>
</p></caption><table frame="hsides" rules="groups"><thead><tr><th>Treatment/outcome</th><th>Benign (n&#x2009;=&#x2009;22)</th><th>Malignant (n&#x2009;=&#x2009;23)</th><th>
<bold><italic>P</italic></bold>-value*</th></tr></thead><tbody><tr><td>Treatment</td><td/><td/><td/></tr><tr><td>Surgery</td><td/><td/><td/></tr><tr><td>Simple excision</td><td>13 (n&#x2009;=&#x2009;18)</td><td>11 (n&#x2009;=&#x2009;20)</td><td/></tr><tr><td>Complex excision</td><td>5 (n&#x2009;=&#x2009;18)</td><td>9 (n&#x2009;=&#x2009;20)</td><td>0.27</td></tr><tr><td>Radiotherapy</td><td>0</td><td>1 (n&#x2009;=&#x2009;23)</td><td/></tr><tr><td>Chemotherapy</td><td>0</td><td>1 (n&#x2009;=&#x2009;23)</td><td/></tr><tr><td>Combination therapy</td><td/><td/><td/></tr><tr><td>Surgery&#x2009;+&#x2009;radiotherapy</td><td>0</td><td>2 (n&#x2009;=&#x2009;23)</td><td/></tr><tr><td>Surgery&#x2009;+&#x2009;Chemotherapy</td><td>0</td><td>0</td><td/></tr><tr><td>Surgery&#x2009;+&#x2009;radio&#x2009;+&#x2009;Chemotherapy</td><td>0</td><td>0</td><td/></tr><tr><td>Recurrent</td><td>2 (n&#x2009;=&#x2009;14)</td><td>2 (n&#x2009;=&#x2009;15)</td><td>0.94</td></tr><tr><td>Imaging features</td><td/><td/><td/></tr><tr><td>Lobular borders</td><td>6 (n&#x2009;=&#x2009;11)</td><td>9 (n&#x2009;=&#x2009;15)</td><td/></tr><tr><td>Smooth borders</td><td>5 (n&#x2009;=&#x2009;11)</td><td>6 (n&#x2009;=&#x2009;15)</td><td>0.78</td></tr><tr><td>Pedicle</td><td>3 (n&#x2009;=&#x2009;11)</td><td>5 (n&#x2009;=&#x2009;16)</td><td>0.82</td></tr><tr><td>Calcification</td><td>2 (n&#x2009;=&#x2009;9)</td><td>0</td><td/></tr><tr><td>Mass effect on mediastinum</td><td>8 (n&#x2009;=&#x2009;9)</td><td>8 (n&#x2009;=&#x2009;13)</td><td>0.16</td></tr><tr><td>Atelectasis</td><td>8 (n&#x2009;=&#x2009;9)</td><td>7 (n&#x2009;=&#x2009;9)</td><td>0.53</td></tr><tr><td>Chest wall involvement</td><td>1 (n&#x2009;=&#x2009;12)</td><td>3 (n&#x2009;=&#x2009;8)</td><td>0.11</td></tr><tr><td>Results of PET CT<sup>$</sup>
</td><td>2 (n&#x2009;=&#x2009;3)</td><td>0</td><td/></tr><tr><td>Benefit of transthoracic needle biopsy</td><td>8 (n&#x2009;=&#x2009;11)</td><td>7 (n&#x2009;=&#x2009;9)</td><td>0.80</td></tr></tbody></table><table-wrap-foot><p>*Pearson <italic>P</italic>-values for all
frequency variables were estimated by individual Chi-square
test.</p><p>
<sup>$</sup>PET CT: positron emission tomography-computed
tomography.</p></table-wrap-foot></table-wrap></p>
      </sec>
    </sec>
    <sec id="Sec8" sec-type="discussion">
      <title>Discussion</title>
      <p>Some criteria, especially England [<xref ref-type="bibr" rid="CR4">4</xref>], are used worldwide to distinguish benign from malignant SFTP
[<xref ref-type="bibr" rid="CR5">5</xref>]. The criteria defined by England
<italic>et al.</italic> [<xref ref-type="bibr" rid="CR4">4</xref>] include high cellularity, pleomorphism with cytonuclear atypia,
more than four mitoses per ten high-power fields, associated necrotic or hemorrhagic
areas. At least 80% of all SFTPs are benign, while the rest may show characteristics
of malignant tumor [<xref ref-type="bibr" rid="CR2">2</xref>, <xref ref-type="bibr" rid="CR4">4</xref>, <xref ref-type="bibr" rid="CR6">6</xref>].
From our study, there are roughly equal numbers of cases between benign and
malignant SFTP with DPS which is higher than 12-13% of malignancy reported in
literature [<xref ref-type="bibr" rid="CR6">6</xref>]. Gender is nearly evenly
distributed between the benign (12 women and 10 men) and malignant (12 women and 11
men), which is different from the results reported by England that DPS was three
times as frequent in females as in males [<xref ref-type="bibr" rid="CR4">4</xref>], probably due to the small number of DPS cases in his study.
Most SFTPs associated with DPS are located in the right lower hemithorax, which is
similar to England&#x2019;s results [<xref ref-type="bibr" rid="CR4">4</xref>]. The
sizes of 100% benign and 95.2% malignant tumors are&#x2009;&gt;&#x2009;10&#xA0;cm, similar to the
conclusion from previous studies [<xref ref-type="bibr" rid="CR2">2</xref>,
<xref ref-type="bibr" rid="CR4">4</xref>].</p>
      <p>Based on the information of 45 cases of SFTP with DPS in our study, the clinical
performances between benign and malignant tumors are almost the same. Local
recurrence can occur in both benign and malignant tumors of SFTP with DPS (two of 14
benign and two of 15 malignant). Surgery is the first effective treatment for both
the original and recurrent benign and malignant masses [<xref ref-type="bibr" rid="CR7">7</xref>&#x2013;<xref ref-type="bibr" rid="CR9">9</xref>].
These findings are also confirmed by our case report. Also, we think the
completeness of initial resection is the key to preventing recurrence of SFTP with
DPS. Some recurrent patients may lose the chance to get re-excision due to
unfavorable health condition after the surgery. For the tumors located in parietal
pleura, complete resection plus extensive excision of the pleura should be adopted
in order to prevent recurrence. It is noteworthy that four cases (three malignant,
one benign) performed transformation from non-hypoglycemia to hypoglycemia and one
recurrent case performed malignant transformation 25&#xA0;years after the surgery
[<xref ref-type="bibr" rid="CR10">10</xref>]. Routine follow-up examinations
are recommended for early detection of recurrent SFTP. Our study also supports the
finding that neither radiotherapy nor chemotherapy has any effect on the treatment
of SFTP with DPS.</p>
    </sec>
    <sec id="Sec9" sec-type="conclusions">
      <title>Conclusions</title>
      <p>Incidence of SFTP with DPS is similar between genders. There are no significant
differences in clinical characteristics between benign and malignant cases. Surgery
is the first effective treatment for SFTP with DPS and the completeness of the
initial resection is the key to preventing recurrence. Routine follow-up
examinations are recommended for early detection of recurrent SFTP with DPS.</p>
    </sec>
    <sec id="Sec10">
      <title>Consent</title>
      <p>Written informed consent was obtained from the patient for publication of this
Case Report and any accompanying images. A copy of the written consent is available
for review by the Editor-in-Chief of this journal.</p>
    </sec>
  </body>
  <back>
    <glossary>
      <title>Abbreviations</title>
      <def-list>
        <def-list>
          <def-item>
            <term>SFTP</term>
            <def>
              <p>Solitary fibrous tumors of pleura</p>
            </def>
          </def-item>
          <def-item>
            <term>DPS</term>
            <def>
              <p>Doege-Potter syndrome</p>
            </def>
          </def-item>
          <def-item>
            <term>IGF-2</term>
            <def>
              <p>Insulin-like growth factor 2.</p>
            </def>
          </def-item>
        </def-list>
      </def-list>
    </glossary>
    <fn-group>
      <fn>
        <p>
          <bold>Competing interests</bold>
        </p>
        <p>Authors have no financial and non-financial competing interests with
anyone or any individual organizations.</p>
      </fn>
      <fn>
        <p>
          <bold>Authors&#x2019; contributions</bold>
        </p>
        <p>WM conducted part of case reports collection, management and analysis, and
drafted the manuscript. HHZ did data correction, conducted part of case reports
collection, did data analysis and interpretation, and co-drafted and revised the
manuscript. HL conducted diagnosis and treatment of patient. GQW performed operation
work on patient. DSW and XF did follow-up work and provided a detailed description
of the patient. All authors read and approved the final manuscript.</p>
      </fn>
    </fn-group>
    <ack>
      <title>Acknowledgements</title>
      <p>The authors thank physicians, nurses and staff in the Department of
Cardiothoracic Surgery, Hangzhou First People&#x2019;s Hospital, for their assistance in
the case diagnosis and treatment.</p>
    </ack>
    <ref-list id="Bib1">
      <title>References</title>
      <ref id="CR1">
        <label>1.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Furukawa</surname>
              <given-names>N</given-names>
            </name>
            <name>
              <surname>Hansky</surname>
              <given-names>B</given-names>
            </name>
            <name>
              <surname>Niedermeyer</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Gummert</surname>
              <given-names>J</given-names>
            </name>
            <name>
              <surname>Renner</surname>
              <given-names>A</given-names>
            </name>
          </person-group>
          <article-title>A silent gigantic solitary fibrous tumor of the
pleura: case report</article-title>
          <source>J Cardiothorac Surg</source>
          <year>2011</year>
          <volume>6</volume>
          <fpage>122</fpage>
          <pub-id pub-id-type="doi">10.1186/1749-8090-6-122</pub-id>
          <pub-id pub-id-type="pmid">21958732</pub-id>
        </element-citation>
      </ref>
      <ref id="CR2">
        <label>2.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Kalebi</surname>
              <given-names>AY</given-names>
            </name>
            <name>
              <surname>Hale</surname>
              <given-names>MJ</given-names>
            </name>
            <name>
              <surname>Wong</surname>
              <given-names>ML</given-names>
            </name>
            <name>
              <surname>Hoffman</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Murray</surname>
              <given-names>J</given-names>
            </name>
          </person-group>
          <article-title>Surgically cured hypoglycemia secondary to pleural
solitary fibrous tumour: case report and update review on the Doege-Potter
syndrome</article-title>
          <source>J Cardiothorac Surg</source>
          <year>2009</year>
          <volume>4</volume>
          <fpage>45</fpage>
          <pub-id pub-id-type="doi">10.1186/1749-8090-4-45</pub-id>
          <pub-id pub-id-type="pmid">19689813</pub-id>
        </element-citation>
      </ref>
      <ref id="CR3">
        <label>3.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Daughaday</surname>
              <given-names>WH</given-names>
            </name>
            <name>
              <surname>Kapadia</surname>
              <given-names>M</given-names>
            </name>
          </person-group>
          <article-title>Significance of abnormal serum binding of insulin-like
growth factor II in the development of hypoglycemia in patients with
non-islet-cell tumors</article-title>
          <source>Proc Natl Acad Sci U S A</source>
          <year>1989</year>
          <volume>86</volume>
          <fpage>6778</fpage>
          <lpage>82</lpage>
          <pub-id pub-id-type="doi">10.1073/pnas.86.17.6778</pub-id>
          <pub-id pub-id-type="pmid">2771956</pub-id>
        </element-citation>
      </ref>
      <ref id="CR4">
        <label>4.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>England</surname>
              <given-names>DM</given-names>
            </name>
            <name>
              <surname>Hochholzer</surname>
              <given-names>L</given-names>
            </name>
            <name>
              <surname>McCarthy</surname>
              <given-names>MJ</given-names>
            </name>
          </person-group>
          <article-title>Localized benign and malignant fibrous tumors of the
pleura. A clinicopathologic review of 223 cases</article-title>
          <source>Am J Surg Pathol</source>
          <year>1989</year>
          <volume>13</volume>
          <fpage>640</fpage>
          <lpage>658</lpage>
          <pub-id pub-id-type="doi">10.1097/00000478-198908000-00003</pub-id>
          <pub-id pub-id-type="pmid">2665534</pub-id>
        </element-citation>
      </ref>
      <ref id="CR5">
        <label>5.</label>
        <element-citation publication-type="book">
          <person-group person-group-type="author">
            <name>
              <surname>Travis</surname>
              <given-names>WD</given-names>
            </name>
            <name>
              <surname>Brambilla</surname>
              <given-names>E</given-names>
            </name>
            <name>
              <surname>Muller-Hermelin</surname>
              <given-names>HK</given-names>
            </name>
            <name>
              <surname>Harriset</surname>
              <given-names>CC</given-names>
            </name>
          </person-group>
          <source>World Health Organization Classification of Tumours. Pathology and
Genetics of Tumours of the Lung, Pleura, thymus and Heart</source>
          <year>2004</year>
          <publisher-loc>Lyon</publisher-loc>
          <publisher-name>IARC Press</publisher-name>
          <fpage>142</fpage>
          <lpage>143</lpage>
        </element-citation>
      </ref>
      <ref id="CR6">
        <label>6.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Zafar</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Takimoto</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Weiss</surname>
              <given-names>G</given-names>
            </name>
          </person-group>
          <article-title>Doege-Potter syndrome: hypoglycemia associated with
malignant solitary fibrous tumor</article-title>
          <source>Med Oncol</source>
          <year>2003</year>
          <volume>20</volume>
          <fpage>403</fpage>
          <lpage>8</lpage>
          <pub-id pub-id-type="doi">10.1385/MO:20:4:403</pub-id>
          <pub-id pub-id-type="pmid">14716039</pub-id>
        </element-citation>
      </ref>
      <ref id="CR7">
        <label>7.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Gold</surname>
              <given-names>JS</given-names>
            </name>
            <name>
              <surname>Antonescu</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Hajdu</surname>
              <given-names>C</given-names>
            </name>
            <name>
              <surname>Ferrone</surname>
              <given-names>CR</given-names>
            </name>
            <name>
              <surname>Hussain</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Lewis</surname>
              <given-names>JJ</given-names>
            </name>
            <name>
              <surname>Brennan</surname>
              <given-names>MF</given-names>
            </name>
            <name>
              <surname>Coit</surname>
              <given-names>DG</given-names>
            </name>
          </person-group>
          <article-title>Clinicopathologic correlates of solitary fibrous
tumors</article-title>
          <source>Cancer</source>
          <year>2002</year>
          <volume>94</volume>
          <fpage>1057</fpage>
          <lpage>68</lpage>
          <pub-id pub-id-type="doi">10.1002/cncr.10328</pub-id>
          <pub-id pub-id-type="pmid">11920476</pub-id>
        </element-citation>
      </ref>
      <ref id="CR8">
        <label>8.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Santos</surname>
              <given-names>RS</given-names>
            </name>
            <name>
              <surname>Haddad</surname>
              <given-names>R</given-names>
            </name>
            <name>
              <surname>Lima</surname>
              <given-names>CE</given-names>
            </name>
            <name>
              <surname>Liu</surname>
              <given-names>YL</given-names>
            </name>
            <name>
              <surname>Misztal</surname>
              <given-names>M</given-names>
            </name>
            <name>
              <surname>Ferreira</surname>
              <given-names>T</given-names>
            </name>
            <name>
              <surname>Boasquevisque</surname>
              <given-names>CH</given-names>
            </name>
            <name>
              <surname>Luketich</surname>
              <given-names>JD</given-names>
            </name>
            <name>
              <surname>Landreneau</surname>
              <given-names>RJ</given-names>
            </name>
          </person-group>
          <article-title>Patterns of recurrence and long-term survival after
curative resection of localized fibrous tumors of the pleura</article-title>
          <source>Clin Lung Cancer</source>
          <year>2005</year>
          <volume>7</volume>
          <fpage>197</fpage>
          <lpage>201</lpage>
          <pub-id pub-id-type="pmid">16354315</pub-id>
        </element-citation>
      </ref>
      <ref id="CR9">
        <label>9.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Robinson</surname>
              <given-names>LA</given-names>
            </name>
          </person-group>
          <article-title>Solitary fibrous tumor of the pleura</article-title>
          <source>Cancer Cause</source>
          <year>2006</year>
          <volume>13</volume>
          <fpage>264</fpage>
          <lpage>9</lpage>
        </element-citation>
      </ref>
      <ref id="CR10">
        <label>10.</label>
        <element-citation publication-type="journal">
          <person-group person-group-type="author">
            <name>
              <surname>Mohamed</surname>
              <given-names>H</given-names>
            </name>
            <name>
              <surname>Mandal</surname>
              <given-names>AK</given-names>
            </name>
          </person-group>
          <article-title>Natural history of multifocal solitary fibrous tumors
of the pleura: a 25-year follow-up report</article-title>
          <source>J Natl Med Assoc</source>
          <year>2004</year>
          <volume>96</volume>
          <fpage>659</fpage>
          <lpage>64</lpage>
          <pub-id pub-id-type="pmid">15160981</pub-id>
        </element-citation>
      </ref>
    </ref-list>
  </back>
</article>
</pmc-articleset>
